Raphael Pharmaceutical (RAPH) Non-Current Assets (2022 - 2025)

Raphael Pharmaceutical (RAPH) has 4 years of Non-Current Assets data on file, last reported at $2000.0 in Q4 2025.

• For the quarter ending Q4 2025, Non-Current Assets changed 0.0% year-over-year to $2000.0; the trailing twelve-month figure through Dec 2025 stood at $8000.0 (down 11.11% YoY), and the FY2025 full-year result was $2000.0, changed 0.0% from the prior year.
• Non-Current Assets was little changed at $2000.0 in Q4 2025, from $2000.0 in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $3000.0 in Q1 2024 to a low of $1000.0 in Q1 2023.
• A 4-year average of $1857.1 and a median of $2000.0 in 2022 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets slumped 50.0% in 2023 and surged 200.0% in 2024, its largest moves.
• Tracing RAPH's Non-Current Assets over 4 years: stood at $2000.0 in 2022, then changed by 0.0% to $2000.0 in 2023, then changed by 0.0% to $2000.0 in 2024, then changed by 0.0% to $2000.0 in 2025.
• Business Quant data shows RAPH's Non-Current Assets at $2000.0 in Q4 2025, $2000.0 in Q3 2025, and $2000.0 in Q2 2025.